The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis
The myelin oligodendrocyte glycoprotein (MOG) is a major target for autoantibody mediated demyelination in experimental autoimmune encephalomyelitis (EAE). In the current review we discuss the epitope specificity of this antibody response, in particular evidence suggesting that pathogenic anti-MOG antibodies are preferentially directed against conformationdependent epitopes present on the extracellular immunoglobulin domain of the protein. Surprisingly, recent data suggest that this autoimmune response is in part regulated by polymorphisms in the MOG gene itself, an observation that may have important implications for the genetic and immunological stratification of patients with multiple sclerosis.
KeywordsMultiple Sclerosis Experimental Autoimmune Encephalomyelitis Experimental Allergic Encephalomyelitis Brown Norway Myelin Debris
Unable to display preview. Download preview PDF.
- Brunner C, Lassmann H, Waehneldt T.V., Matthieu J-M, Linington C (1989) Differential ultrastructurallocalization of myelin basic protein, myelin/oligodendrocyte glycoprotein, and 2’,3’-cyclic nucleotide 3’-phosphodiesterase in the CNS of adult rats. J Neurochem 52: 296–304PubMedCrossRefGoogle Scholar
- Ichikawa M, Johns T.G., Liu J, Bernard C.C. (1996) Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J Immunol 157: 919–926PubMedGoogle Scholar
- Ichikawa M, Koh C.S., Inaba Y, Seki C, Inoue A, Itoh M, Ishihara Y, Bernard C.C., Komiyama A (1999) IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. Cell Immunol 191: 97–104PubMedCrossRefGoogle Scholar
- Kerlero de Rosbo N, Hoffman M, Mendel I, Yust I, Kaye J, Bakimer R, et al. (1997) Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol 27: 3059–3069CrossRefGoogle Scholar
- Lambracht D, Prokop C, Hedrich H.J., Fischer Lindahl K, Wonigeit K (1995) Mapping of H2-M homolog and MOG genes in the rat MHC. Immunogen 42: 418–421Google Scholar
- Lebar R, Lubetzki C, Vincent C, Lombrail P, Poutry J-M (1986) The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membranes. Clin Exp Immunol 66: 432–443Google Scholar
- Pham-Dinh D, Mattei M.G., Nussbaum J.L., Roussel G, Pontarotti P, Roeckel N, Mather IH, Artzt K, Lindahl K.F., Dautigny A (1993) Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci USA 90: 7990–7994PubMedCrossRefGoogle Scholar